Chinese herbal medicine for SARS and SARS-CoV-2 treatment and prevention, encouraging using herbal medicine for COVID-19 outbreak

被引:54
作者
Shahrajabian, Mohamad Hesam [1 ]
Sun, Wenli [1 ]
Shen, Hong [2 ]
Cheng, Qi [1 ,3 ,4 ]
机构
[1] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China
[2] Zhejiang Inst Food & Drug Control, NMPA Key Lab Testing & Risk Warning Pharmaceut M, Biol Inspect Dept, Hangzhou, Peoples R China
[3] Hebei Agr Univ, Coll Life Sci, Baoding 071000, Hebei, Peoples R China
[4] Global Alliance HeBAU CLS&HeQiS BioAl Mfg, Baoding 071000, Hebei, Peoples R China
关键词
SARS; SARS-CoV-2; Licorice; traditional herbal plants; GLYCYRRHIZIC ACID; ANTIMICROBIAL ACTIVITIES; ANTIVIRAL ACTIVITIES; CORONAVIRUS; REPLICATION; DERIVATIVES; INFECTION; EXTRACT; PLANTS;
D O I
10.1080/09064710.2020.1763448
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Chinese herbs and plants have been used as traditional medicine, immune system booster for human being for thousands of years in China and other parts of Asia. Seven coronaviruses are known to infect humans, three of them are serious which are SARS (severe acute respiratory syndrome), MERS (Middle East respiratory syndrome), and SARS-CoV-2 (Covid-19). In this mini-review article, we have mentioned the key role some of the most important plants with antiviral activities and herbs against SARS and SARS-CoV-2 on the basis of traditional Chinese medicine.
引用
收藏
页码:437 / 443
页数:7
相关论文
共 55 条
  • [1] Al-Shukaili NBMB, 2019, GRAIN OIL SCI TECHNO, V2, P103, DOI DOI 10.1016/J.GAOST.2019.11.001
  • [2] 최화정, 2008, [KOREAN JOURNAL OF MEDICINAL CROP SCIENCE, 한국약용작물학회지], V16, P273
  • [3] Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication
    Chen, Chung-Jen
    Michaelis, Martin
    Hsu, Hseng-Kuang
    Tsai, Chin-Chuan
    Yang, Kunder D.
    Wu, Yang-Chang
    Cinatl, Jindrich, Jr.
    Doerr, Hans Wilhelm
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2008, 120 (01) : 108 - 111
  • [4] In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
    Chen, F
    Chan, KH
    Jiang, Y
    Kao, RYT
    Lu, HT
    Fan, KW
    Cheng, VCC
    Tsui, WHW
    Hung, IFN
    Lee, TSW
    Guan, Y
    Peiris, JSM
    Yuen, KY
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (01) : 69 - 75
  • [5] Binding interaction of quereetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro:: Structure-activity relationship studies reveal salient pharmacophore features
    Chen, Lili
    Li, Jian
    Luo, Cheng
    Liu, Hong
    Xu, Weijun
    Chen, Gang
    Liew, Oi Wah
    Zhu, Weiliang
    Puah, Chum Mok
    Shen, Xu
    Jiang, Hualiang
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) : 8295 - 8306
  • [6] Antiviral effects of saikosaponins on human coronavirus 229E in vitro
    Cheng, Pei-Win
    Ng, Lean-Teik
    Chiang, Lien-Chai
    Lin, Chun-Ching
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (07): : 612 - 616
  • [7] In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids
    Chiang, LC
    Chiang, W
    Liu, MC
    Lin, CC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) : 194 - 198
  • [8] Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection
    Chiow, K. H.
    Phoon, M. C.
    Putti, Thomas
    Tan, Benny K. H.
    Chow, Vincent T.
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2016, 9 (01) : 1 - 7
  • [9] Antiviral activity of maca (Lepidium meyenii) against human influenza virus
    del Valle Mendoza, Juana
    Pumarola, Tomas
    Alzamora Gonzales, Libertad
    del Valle, Luis J.
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2014, 7 : S415 - S420
  • [10] The evaluation of sterile solutions of Ilwensisaponin A and C from Verbascum pterocalycinum var. mutense Hub.-Mor. on antiviral, antinociceptive and anti-inflammatory activities
    Diker, N. Yagmur
    Kahraman, Cigdem
    Akkol, Esra Kupeli
    Karaoglu, M. Taner
    Comoglu, Tansel
    Akdemir, Zeliha S.
    Cankaya, I. Irem Tatli
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2019, 27 (03) : 432 - 436